Financial Daily from THE HINDU group of publications
Thursday, Mar 10, 2005

News
Features
Stocks
Port Info
Archives
Google

Group Sites

Corporate - New Projects


India to become sourcing centre for Fresenius Kabi

Our Bureau

New Delhi , March 9

INDIA is poised to become one of the biggest sourcing centres for the German healthcare company Fresenius Kabi AG. The company's wholly-owned subsidiary is upgrading its manufacturing facilities to the European Good Manufacturing Practice (EU GMP) standards.

Speaking to Business Line, Mr Rakesh Bhargava, Managing Director and CEO, Fresenius Kabi India Pvt Ltd, said, "Fresh investments will be made to upgrade the manufacturing facility at Ranjangaon, near Pune.

"We hope to get our approvals from the EU regulators by the end of this year. This will enable us to service many countries in Europe, Australia as well as in the Asia-Pacific region. Later we hope to get approvals for the US markets as well."

The company manufactures parenterals (drugs administered by injection under or through one or more layers of skin or mucous membrane) and markets blood replacement products, clinical nutrition, intravenous fluids and infusion devices in India.

According to Mr Mats Henriksson, Member of the Management Board and President of the Asia-Pacific region, Fresenius Kabi, "India is a high priority market for the group and this evident from the large financial commitments made by the parent.

"We have invested about Rs 97 crore in equity and Rs 77 crore in fixed assets. The total sales from the market is about is about Rs 76.6 crore."

Article E-Mail :: Comment :: Syndication :: Printer Friendly Page


Stories in this Section
Fire at Aurobindo Pharma unit; one killed


Sundaram-Clayton sets up unit to develop software for WABCO
Tata Tea (GB)'s debt-equity ratio gets lowered
Sybly Ind gets Rs 3.5-cr order from Turkey
Natco Pharma gets European patent for soft gel capsules
Himalya Intl bags Rs 5.4-cr US order
Govt may ease norms for ECBs — Curbs on foreign currency convertible bonds to go
India to become sourcing centre for Fresenius Kabi
Zydus announces US generics foray
Tasc Pharma board to meet on tie-up with Glenmark Labs
Vybra Auto to convert unsecured loans into equity
SAIL lines up Rs 4,500 cr to spruce up Rourkela plant
Indonesian vaccine co seeks support for WHO re-listing
Ashok Leyland vehicle sales up in February
Bajaj Auto elevates Rajiv to MD post; Rahul Bajaj is Chairman
Pfizer MD quits


The Hindu Group: Home | About Us | Copyright | Archives | Contacts | Subscription
Group Sites: The Hindu | Business Line | The Sportstar | Frontline | The Hindu eBooks | The Hindu Images | Home |

Copyright © 2005, The Hindu Business Line. Republication or redissemination of the contents of this screen are expressly prohibited without the written consent of The Hindu Business Line